Helping Biotron to Do Better and Deliver Tangible Results: Shareholders Call for ASIC Action and Regulatory Scrutiny, page-13

My intention has never been to give the management a hard time. I have consistently raised concerns with the hope that ASIC will guide the company’s leadership to fulfil their legal and ethical obligations to shareholders.

The petition I submitted — and the issues it raises — are not acts of hostility. They are constructive calls for greater transparency, accountability, and improved governance. This initiative is intended as a note of encouragement, urging management to act in the best interests of all shareholders.

By reaching out to ASIC, I hope to encourage other shareholders to do the same — not to dismantle or discredit the company, but to help ensure that Biotron is managed transparently, responsibly, and with a focus on real outcomes.

We all want the company to succeed. But true success must be driven by tangible results, open communication, and a fair alignment between executive compensation and actual performance.

I also encourage others to approach regulators with their own concerns, as they see fit. Many community members and posters — including FM, GY, Lux, and others — have contributed valuable insights from different perspectives. My petition incorporates a combination of views from both holders and non-holders, and it can serve as a baseline for others seeking to engage with regulators and help guide Biotron’s management in the right direction — for the benefit of all stakeholders.